<DOC>
	<DOCNO>NCT00004580</DOCNO>
	<brief_summary>The purpose study see safe effective give ABT-378/ritonavir combination plus nevirapine plus two nucleoside transcriptase inhibitor HIV-infected patient previously take protease inhibitor . This study also examine body handle combination anti-HIV drug .</brief_summary>
	<brief_title>A Study ABT-378/Ritonavir Combination HIV-Infected Patients Who Have Taken Protease Inhibitors</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>HIV Protease Inhibitors</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<mesh_term>Protease Inhibitors</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Antiretroviral regimen contain protease inhibitor one two nucleoside reverse transcriptase inhibitor change last 12 week . Patients must : HIV infection plasma HIV RNA least 1,000 copies/ml less equal 100,000 copies/ml screening . Prior Medication : Allowed : Naive less 8 week least one nucleoside reverse transcriptase inhibitor acceptable regimen two nucleoside reverse transcriptase inhibitor . Exclusion Criteria Concurrent Medication : Excluded : Medications contraindicate ABT378/ritonavir duration study , midazolam , triazolam , terfenadine , astemizole , cisapride , pimozide , ergotamine dihydroergotamine . Overthecounter medicine alcohol , without knowledge permission investigator . Patients follow prior condition exclude : Evidence acute illness determine vital sign , physical examination , laboratory result . Clinically significant abnormal ECG result . Positive test result drug abuse exception cannabis , unless investigator anticipates cannabis use interfere compliance study . Prior Medication : Excluded : Investigational drug exception Amprenavir within 28 day prior initiation study dose . Treatment nonnucleoside reverse transcriptase inhibitor . Treatment protease inhibitor different current protease inhibitor 6 week prior current regimen . Treatment one protease inhibitor concurrently . Risk Behavior : Excluded : Active substance abuse , alcohol abuse , psychiatric illness . Presumption , investigator , poor compliance regimen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Nevirapine</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>Ritonavir</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
</DOC>